Literature DB >> 24606423

Matrix metalloproteinases and cancer - roles in threat and therapy.

Lalita Yadav1, Naveen Puri, Varun Rastogi, Pranali Satpute, Riyaz Ahmad, Geetpriya Kaur.   

Abstract

Matrix metalloproteinases (MMPs) are a family of zinc dependent extracellular matrix (ECM) remodelling endopeptidases having the ability to degrade almost all components of extracellular matrix and implicated in various physiological as well as pathological processes. Carcinogenesis is a multistage process in which alteration of the microenvironment is required for conversion of normal tissue to a tumour. Extracellular matrix remodelling proteinases such as MMPs are principal mediators of alterations observed in the microenvironment during carcinogenesis and according to recent concepts not only have roles in invasion or late stages of cancer but also in regulating initial steps of carcinogenesis in a favourable or unfavourable manner. Establishment of relationships between MMP overproduction and cancer progression has stimulated the development of inhibitors that block proteolytic activity of these enzymes. In this review we discuss the MMP general structure, classification, regulation roles in relation to hallmarks of cancer and as targets for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24606423     DOI: 10.7314/apjcp.2014.15.3.1085

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  78 in total

1.  Cyclodextrin mediated delivery of NF-κB and SRF siRNA reduces the invasion potential of prostate cancer cells in vitro.

Authors:  J C Evans; J McCarthy; C Torres-Fuentes; J F Cryan; J Ogier; R Darcy; R W Watson; C M O'Driscoll
Journal:  Gene Ther       Date:  2015-05-25       Impact factor: 5.250

2.  Capn4 promotes non-small cell lung cancer progression via upregulation of matrix metalloproteinase 2.

Authors:  Jie Gu; Feng-kai Xu; Guang-yin Zhao; Chun-lai Lu; Zong-wu Lin; Jian-yong Ding; Di Ge
Journal:  Med Oncol       Date:  2015-01-31       Impact factor: 3.064

Review 3.  Circulating glioma biomarkers.

Authors:  Johan M Kros; Dana M Mustafa; Lennard J M Dekker; Peter A E Sillevis Smitt; Theo M Luider; Ping-Pin Zheng
Journal:  Neuro Oncol       Date:  2014-09-24       Impact factor: 12.300

4.  Natriuretic peptide receptor a promotes breast cancer development by upregulating MMP9.

Authors:  Jingkun Qu; Xixi Zhao; Xu Liu; Yuchen Sun; Jizhao Wang; Lin Liu; Jiansheng Wang; Jia Zhang
Journal:  Am J Cancer Res       Date:  2019-07-01       Impact factor: 6.166

5.  Expression of MMP14 in invasive pituitary adenomas: relationship to invasion and angiogenesis.

Authors:  Pinjing Hui; Xu Xu; Lan Xu; Guozhen Hui; Shiliang Wu; Qing Lan
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

6.  MMP-14 and TGFβ-1 methylation in pituitary adenomas.

Authors:  Kornelija Ruskyte; Rasa Liutkevicienė; Alvita Vilkeviciute; Paulina Vaitkiene; Indre Valiulytė; Brigita Glebauskiene; Loresa Kriauciuniene; Dalia Zaliuniene
Journal:  Oncol Lett       Date:  2016-07-29       Impact factor: 2.967

7.  Association and Prognostic Significance of the Functional -1562C/T Polymorphism in the Promoter Region of MMP-9 in Turkish Patients with Gastric Cancer.

Authors:  Nilufer Avcı; Mehmet Ture; Adem Deligonul; Erdem Cubukcu; Omer Fatih Olmez; Serdar Sahinturk; Ali Topak; Ender Kurt; Turkkan Evrensel; Ahmet Bilgehan Şahin; Tahsin Yakut
Journal:  Pathol Oncol Res       Date:  2015-07-09       Impact factor: 3.201

8.  Tauroursodeoxycholic acid reduces the invasion of MDA-MB-231 cells by modulating matrix metalloproteinases 7 and 13.

Authors:  Ga-Young Park; Yu Kyeong Han; Jeong Yoon Han; Chang Geun Lee
Journal:  Oncol Lett       Date:  2016-07-11       Impact factor: 2.967

9.  Aurora-A modulates MMP-2 expression via AKT/NF-κB pathway in esophageal squamous cell carcinoma cells.

Authors:  Xiaoxia Wang; Xiaozhong Li; Chaohui Li; Chun He; Benhong Ren; Qing Deng; Wei Gao; Binquan Wang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-04-28       Impact factor: 3.848

10.  Dehydroepiandrosterone inhibits events related with the metastatic process in breast tumor cell lines.

Authors:  Rebeca López-Marure; Estrella Zapata-Gómez; Leticia Rocha-Zavaleta; María Cecilia Aguilar; Magali Espinosa Castilla; Jorge Meléndez Zajgla; Noemí Meraz-Cruz; Claudia Huesca-Gómez; Ricardo Gamboa-Ávila; Erika Olivia Gómez-González
Journal:  Cancer Biol Ther       Date:  2016-06-03       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.